Our Facilities

Our advanced pharmaceutical R&D facility is a place where ideas turn into real solutions. Built to support research and early-stage development, it brings together modern laboratories, pilot-scale production capabilities, and a collaborative setting where pharmaceutical processes can be tested, refined, and improved. Designed to meet strict regulatory and quality standards, we offer both the expertise and the resources needed to move concepts toward viable products. Whether you’re creating new formulations, improving existing processes, or running small-scale trials, our facility is here to support innovation and help speed your path to market.

Our world-class infrastructure includes:

Advanced Analytical Instruments

✅ Malvern Mastersizers – Ensures precise particle size analysis for complex drug formulations.
✅ USP Type 3 Dissolution Apparatus – Provides detailed dissolution insights for extended release and delayed release drug formulations.
✅ Ultra-High-Performance Liquid Chromatography (UHPLC) – Enables rapid and high-resolution separation of pharmaceutical compounds.
✅ Fourier Transform Infrared Spectroscopy (FTIR) – Facilitates in-depth molecular fingerprinting and quality control.
✅ Differential Scanning Calorimetry (DSC) – Assesses thermal stability and compatibility of drug formulations.
✅ Gas Chromatography Instruments – Helps separate, identify and quantify compounds in a sample.

Cutting-edge Formulation Equipments

✅ High-Shear Granulators – Optimizes wet granulation for enhanced tablet formulation.
✅ Fluid Bed Dryers – Ensures efficient drying and coating of pharmaceutical powders.
✅ Nano-Milling & Microfluidization Systems – Achieves ultra-fine particle sizes for improved bioavailability.
✅ Spray Drying Technology – Enables precise control over particle morphology for inhalable and injectable formulations.
✅ Multi-Layer Tablet Press – Supports complex formulations by enabling dual or multi-layered tablet production.
✅ Encapsulation Machines – Facilitates precise filling of capsules for powders, granules, and liquid formulations. 

With these world-class capabilities, our R&D facility is designed to drive breakthrough pharmaceutical innovations, ensuring the highest quality and compliance with global regulatory standards.

We’re excited to share a major step forward in our research and development journey, with an expanded focus on hormone and anti-cancer research. Alongside this growth, we’re launching a cutting-edge pilot plant designed to speed up the development of promising new therapies. By combining AI-powered clinical research with scalable production capabilities, we’re working to bring innovative treatments to patients faster than ever. This milestone reflects our ongoing commitment to improving healthcare, delivering better patient outcomes, and helping shape the future of pharmaceutical innovation. We remain focused on driving progress and delivering meaningful advancements that shape the future of medicine.